Company / SG&A per Share
Phathom Pharmaceuticals, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.08
FY2025
5-year range
$1.70 / $4.08
FY2021-FY2025
Trend
+100.7%
vs FY2024
Sector context
#44 of 210
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s sg&a per share of $4.08 is higher than 79% of companies in the Health Care sector (FY2025). Increased from $2.84 to $4.08 over the past 2 years.
Based on SEC 10-K filings.
4.08 in FY2025 with a 5-year CAGR of +37.6%. Top quartile in the Health Care sector.
Increased from $2.84 to $4.08 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +16.5%
- 5-Year CAGR
- +37.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 210This company $4.08 Sector average $29.50
▼
-86.2% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 100.7% year-over-year.
- Ranks #44 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.08 | +100.7% |
| FY2024 | $2.03 | -28.5% |
| FY2023 | $2.84 | +10.1% |
| FY2022 | $2.58 | +52.3% |
| FY2021 | $1.70 | +104.8% |
| FY2020 | $0.83 | +35.6% |
| FY2019 | $0.61 | +206.8% |
| FY2018 | $0.20 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026